SPECIAL NOTICE
A -- Out-Patient Drug Treatment Research Clinic
- Notice Date
- 7/10/2014
- Notice Type
- Special Notice
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- N01DA-10-9913-01
- Archive Date
- 8/9/2014
- Point of Contact
- Andrew Hotaling, Phone: 301.443.6677, Kenneth E Goodling, Phone: (301)443-6677
- E-Mail Address
-
hotalingar@mail.nih.gov, kg25d@nih.gov
(hotalingar@mail.nih.gov, kg25d@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a notice of intent to award a sole source modification under current Contract No. HHSN271201000002C (NIDA Ref. No. N01DA-10-9913) with Johns Hopkins Bayview Medical Center of Baltimore, MD, to continue the services offered under the contract for a period not to exceed 12 months. The objective of the current contract is to provide the NIDA Intramural Research Program (IRP) with continuous, ongoing, recurring clinical services and clinical management that will support a 60-slot outpatient drug treatment research program (the Archway Clinic). Under the proposed modification, the Contractor will provide the NIDA/IRP with clinical services and clinical management to support a 30-slot outpatient drug treatment research program (the Archway Clinic), while phasing out the Clinic to closure. This notice is being published by NIH/NIDA in accordance with Federal Acquisition Regulation (FAR) 5.201. The statutory authority for this sole source modification is FAR 6.302-1, Only One Responsible Source. This notice of intent is not a request for competitive proposals. However, the Government shall consider all responses received within fifteen days of this posting. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely at the discretion of the Government. Written responses to this synopsis shall contain sufficient documentation to establish a bona fide capability to fulfill this requirement. NIDA will not be responsible for any costs incurred by interested parties responding to this notice.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/N01DA-10-9913-01/listing.html)
- Place of Performance
- Address: 251 Bayview Boulevard, Baltimore, Maryland, 21224, United States
- Zip Code: 21224
- Zip Code: 21224
- Record
- SN03421412-W 20140712/140710235816-d77532789f7fc1b92a491bf00138a416 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |